SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-20-005972
Filing Date
2020-01-22
Accepted
2020-01-22 17:03:26
Documents
2
Period of Report
2020-01-20

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm205452-6_4.html 4  
1 OWNERSHIP DOCUMENT tm205452-6_4.xml 4 4132
2 EXHIBIT 24 tm205452-6_ex24.htm EX-24 5300
  Complete submission text file 0001104659-20-005972.txt   11002
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Issuer) CIK: 0001006281 (see all company filings)

IRS No.: 650643773 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 6225 NEIL ROAD RENO NV 89511
Business Address
Granot David (Reporting) CIK: 0001551620 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33357 | Film No.: 20539488